Effect of hypoventilation on bleeding during hepatic resection: a randomized controlled trial

Arch Surg. 2002 Mar;137(3):311-5. doi: 10.1001/archsurg.137.3.311.

Abstract

Hypothesis: Blood loss in hepatic resection is an important determinant of operative outcome.

Objective: To clarify whether reducing the tidal volume would be effective in decreasing blood loss during liver transection.

Design: Randomized controlled trial.

Setting: University hospital.

Patients: Eighty patients scheduled to undergo hepatic resection were randomly assigned to receive liver transection under normoventilation (n = 40) or hypoventilation (n = 40).

Interventions: During liver transection, in the normoventilation group, the tidal volume was 10 mL/kg and the respiratory rate was 10/min; in the hypoventilation group, the tidal volume was reduced to 4 mL/kg and respiratory rate was increased to 15/min. Liver transection was performed under total or selective inflow occlusion.

Main outcome measure: Blood loss.

Results: Between the normoventilation and hypoventilation groups, no significant difference was found in total blood loss (median [range]: 630 mL [72-3600 mL] vs 630 mL [120-3520 mL]; P =.44) or blood loss per transection area (median [range]: 7.3 mL/cm(2) [1.2-55.4 mL/cm(2)] vs 9.8 mL/cm(2) [0.9-79.9 mL/cm(2)]; P =.55). During liver transection, the central venous pressure was significantly reduced in the hypoventilation group than in the normoventilation group (median [range]: -0.7 cm H(2)O [-3.0 to 1.8 cm H(2)O] vs -0.2 cm H(2)O [-4.0 to 2.0 cm H(2)O]; P =.007). The maximum end-tidal carbon dioxide level in the hypoventilation group was significantly higher than that in the normoventilation group (maximum [range]: 50 mm Hg [28-66 mm Hg] vs 37 mm Hg [27-60 mm Hg]; P<.001). Transection time, postoperative liver function, hospitalization length, morbidity, and mortality were similar in the 2 groups.

Conclusion: This randomized trial suggested no beneficial effect of reduction of tidal volume on bleeding during hepatic resection.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Loss, Surgical / prevention & control*
  • Hepatectomy / adverse effects*
  • Hepatectomy / methods*
  • Humans
  • Liver Neoplasms / physiopathology
  • Liver Neoplasms / surgery
  • Postoperative Hemorrhage / etiology
  • Postoperative Hemorrhage / prevention & control
  • Respiration*
  • Tidal Volume*
  • Treatment Outcome